BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bolli R, Solankhi M, Tang XL, Kahlon A. Cell Therapy in Patients with Heart Failure: A Comprehensive Review and Emerging Concepts. Cardiovasc Res 2021:cvab135. [PMID: 33871588 DOI: 10.1093/cvr/cvab135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Hoang DM, Pham PT, Bach TQ, Ngo ATL, Nguyen QT, Phan TTK, Nguyen GH, Le PTT, Hoang VT, Forsyth NR, Heke M, Nguyen LT. Stem cell-based therapy for human diseases. Signal Transduct Target Ther 2022;7:272. [PMID: 35933430 DOI: 10.1038/s41392-022-01134-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Matta A, Nader V, Lebrin M, Gross F, Prats A, Cussac D, Galinier M, Roncalli J. Pre-Conditioning Methods and Novel Approaches with Mesenchymal Stem Cells Therapy in Cardiovascular Disease. Cells 2022;11:1620. [DOI: 10.3390/cells11101620] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Braunwald E. Cardiac cell therapy: a call for action. Eur Heart J 2022:ehac188. [PMID: 35417529 DOI: 10.1093/eurheartj/ehac188] [Reference Citation Analysis]
4 Zhang J, Bolli R, Garry DJ, Marbán E, Menasché P, Zimmermann WH, Kamp TJ, Wu JC, Dzau VJ. Basic and Translational Research in Cardiac Repair and Regeneration: JACC State-of-the-Art Review. J Am Coll Cardiol 2021;78:2092-105. [PMID: 34794691 DOI: 10.1016/j.jacc.2021.09.019] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
5 Yamada S, Bartunek J, Behfar A, Terzic A. Mass Customized Outlook for Regenerative Heart Failure Care. Int J Mol Sci 2021;22:11394. [PMID: 34768825 DOI: 10.3390/ijms222111394] [Reference Citation Analysis]
6 Taylor DA, Chacon-Alberty L, Sampaio LC, Del Hierro MG, Perin EC, Mesquita FCP, Henry TD, Traverse JH, Pepine CJ, Hare JM, Murphy MP, Yang PC, March KL, Vojvodic RW, Ebert RF, Bolli R; Cardiovascular Cell Therapy Research Network (CCTRN). Recommendations for Nomenclature and Definition Of Cell Products Intended for Human Cardiovascular Use. Cardiovasc Res 2021:cvab270. [PMID: 34387303 DOI: 10.1093/cvr/cvab270] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Maar K, Hetenyi R, Maar S, Faskerti G, Hanna D, Lippai B, Takatsy A, Bock-Marquette I. Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4 to Remind the Adult Organs of Their Embryonic State-New Directions in Anti-Aging Regenerative Therapies. Cells 2021;10:1343. [PMID: 34071596 DOI: 10.3390/cells10061343] [Reference Citation Analysis]